痰热清注射液在慢性阻塞性肺疾病急性加重期治疗中的地位评价

摘要

Objective intravenous Tanreqing injection clinical curative effect of Tanreqing Injection on acute exacerbation of chronic obstructive pulmonary disease (AECOPD) through to treatment status.Methods 60 patients with AECOPD were randomly divided into two groups, 30 cases in each group. The control group was given conventional treatment, the treatment group on the basis of conventional therapy plus Tanreqing injection, compare two groups of patients improved or clinical remission. ResultsThe patients in the treatment group compared to the control group of patients in hospitalization days, days of antibiotic application, pulmonary wheezing, C reactive protein, neutrophil count, blood gas analysis, there are signiifcant differences.Conclusion Combined with tanreqing injection, compared with the conventional treatment group significantly improved clinical effcacy, relieve the pain of patients.%目的：通过观察静脉滴注痰热清注射液临床疗效探讨痰热清注射液在慢性阻塞性肺疾病急性加重期（AECOPD）的治疗地位。方法选择60例AECOPD患者，采用随机数字表法分为两组，每组30例。对照组采用常规治疗方法，治疗组在常规治疗基础上加用痰热清注射液静脉滴注，比较两组病例病情好转或临床缓解情况。结果治疗组患者相比对照组患者在住院天数、抗生素应用天数、肺内哮鸣音、C反应蛋白、中性粒细胞计数、血气分析等方面有显著差异。结论加用痰热清注射液静脉滴注，较常规治疗组临床疗效明显改善，减轻患者痛苦。